We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pharma Could Get Policy Boost from Executive Order
Pharma Could Get Policy Boost from Executive Order
The White House could be pushing for lower prices by way of speeding drugs to market and promoting competition—even internationally—according to a draft executive order that could have the president’s signature soon
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor